Malin Sendelius

Title: The Innovations of Malin Sendelius

Introduction

Malin Sendelius is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of metabolic engineering. With a total of 2 patents, his work focuses on the production of valuable compounds through genetically engineered micro-organisms.

Latest Patents

Sendelius's latest patents include innovative methods for producing pinosylvin. His patented technology involves metabolically engineered cells that utilize an operative metabolic pathway to produce cinnamoyl-CoA, which is then converted into pinosylvin by the action of a stilbene synthase. The process also involves the formation of cinnamic acid from L-phenylalanine through the enzyme L-phenylalanine ammonia lyase (PAL). This intricate method ensures that the ratios of various substrates and enzymes are optimized for efficient production.

Career Highlights

Throughout his career, Malin Sendelius has worked with several prominent companies, including Fluxome Sciences A/S and Evolva SA. His experience in these organizations has allowed him to develop and refine his innovative approaches to biotechnology.

Collaborations

Some of his notable coworkers include Michael Katz and Helga David, who have contributed to his research and development efforts.

Conclusion

Malin Sendelius's work exemplifies the intersection of innovation and biotechnology, showcasing how metabolic engineering can lead to the production of valuable compounds. His contributions continue to influence the field and inspire future advancements.